| Product NDC: | 0093-5050 |
| Proprietary Name: | Pioglitazone and Metformin Hydrocholride |
| Non Proprietary Name: | pioglitazone and metformin hydrochloride |
| Active Ingredient(s): | 850; 15 mg/1; mg/1 & nbsp; pioglitazone and metformin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-5050 |
| Labeler Name: | Teva Pharmaceuticals USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021842 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120817 |
| Package NDC: | 0093-5050-06 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0093-5050-06) |
| NDC Code | 0093-5050-06 |
| Proprietary Name | Pioglitazone and Metformin Hydrocholride |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0093-5050-06) |
| Product NDC | 0093-5050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pioglitazone and metformin hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120817 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Teva Pharmaceuticals USA |
| Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 850; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |